Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018

Bill: 115-hr-6110
Sponsor: Rep. Walorski, Jackie [R-IN-2]
Introduced: 2018-06-14 in the House
Policy area: Health
Subjects: Alternative treatments
Congressional oversight
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Fraud offenses and financial crimes
Government information and archives
Government studies and investigations
Health care coverage and access
Health facilities and institutions
Health personnel
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Home and outpatient care
Hospital care
Medicare
Mental health
Military medicine
Retail and wholesale trades
Rural conditions and development
Surgery and anesthesia
Veterans' medical care

Summary:
action_date: 2018-06-14
text: 

Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018

 
This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage (MA), related to pain management and opioid use. 
 
 Among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly.
 
The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine). 
 
 The bill also authorizes the suspension of payments to a pharmacy under the Medicare prescription drug benefit and MA prescription drug plans pending the investigation of a credible allegation of fraud by the pharmacy. 

action_date: 2018-06-19
text: 

Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018

 
This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage (MA), related to pain management and opioid use. 
 
 Among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly.
 
The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine). 
 
 The bill also authorizes the suspension of payments to a pharmacy under the Medicare prescription drug benefit and MA prescription drug plans pending the investigation of a credible allegation of fraud by the pharmacy. 


Legislative actions:
action_date: 2018-06-25
text: Referred to the Subcommittee on Health.
action_date: 2018-06-20
text: Received in the Senate and Read twice and referred to the Committee on Finance.
action_date: 2018-06-19
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2018-06-19
text: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5250-5252)
action_date: 2018-06-19
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5250-5252)
action_date: 2018-06-19
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 6110.
action_date: 2018-06-19
text: Considered under suspension of the rules. (consideration: CR H5249-5254)
action_date: 2018-06-19
text: Mrs. Walorski moved to suspend the rules and pass the bill.
action_date: 2018-06-14
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2018-06-14
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2018-06-14
text: Introduced in House
action_date: 2018-06-14
text: Introduced in House